Shares of Oklo (OKLO) fell sharply on Tuesday after Wolfe Research initiated coverage on the advanced nuclear reactor company with a cautious “Peer Perform” (hold) rating, raising fresh concerns about valuation, execution risks, and the company's long path toward commercialization. Oklo stock dropped more than 6% in morning trading after Wolfe analyst Steve Fleishman outlined a fair valuation range of roughly $51 to $71 per share.
OKLO beat Q1 loss expectations, sits on some $2.5B liquidity, and advances NRC work plus META and NVIDIA tie-ins to AI data-center power.
Oklo (NYSE:OKLO) shares fell about 6% on Wednesday after the advanced nuclear technology company reported a wider first-quarter loss as spending increased to support development of its Aurora powerhouse program and related infrastructure projects. The company posted a Q1 net loss of $33.1 million, compared with a loss of $17.9 million a year earlier.
Oklo NYSE: OKLO reported a wider first-quarter 2026 loss as the advanced nuclear developer said it is moving further into asset deployment across its power, fuel and isotope businesses.
Oklo Inc. (OKLO) Q1 2026 Earnings Call Transcript
Oklo is scheduled to report its latest quarterly results after the market closes Tuesday, with traders anticipating a big swing in the nuclear startup's stock following the report.
Oklo's nuclear technology is tailor-made for AI data centers. SMR technology has a long growth runway ahead.
Shares of NANO Nuclear Energy (NASDAQ:NNE) are down 10% midday Thursday, trading near $26.
As OKLO gears up to report first-quarter earnings on May 12, let's find out how the expectations stack up. Also, know how to play the stock ahead of results.
Oklo receives a Speculative Buy rating based on its differentiated reactor technology and upcoming operational catalysts, despite being deeply unprofitable and pre-commercial. OKLO's fast-neutron, sodium-cooled Aurora reactor design aims for lower construction and operational costs, though initial burnup efficiency will be below 1%. Key near-term catalysts include Groves Isotopes test reactor achieving criticality and first revenue from medical isotope production, expected in the final quarter of this year.
Oklo is rated a Buy, driven by its vertically integrated SMR technology, unique fuel recycling, and strong AI-driven power demand. OKLO's regulatory strategy leverages the DOE Pilot Program, enabling faster deployment and operational data collection ahead of NRC licensure. Major agreements with Meta, Switch, and Equinix signal robust demand, with even modest execution potentially yielding hundreds of millions in high-margin EBITDA.
Oklo shares rose on Thursday after the company announced a partnership with Nvidia, marking its latest effort to build investor confidence as it advances toward commercial deployment of its nuclear technology. The stock gained about 6.3% to $77.02 following the announcement.